Indian drug makers wary as US FDA sharpens focus on quality controlPost published:May 16, 2017Post category:Industry NewsThe US FDA has increased the frequency of its inspections but also intensified scrutiny on drug manufacturing facilities in India Source: Livemint.com (http://www.livemint.com/rss/industry)Read more articles Previous PostFacebook’s Sheryl Sandberg urges family-friendly policies on Mother’s Day Next PostLithium supply may be key to government’s electric vehicles push You Might Also Like IoT Connectivity with No Programming Required? Si Labs Releases New Wi-Fi and Bluetooth Modules September 29, 2018 Mahindra Finance plans to raise up to Rs2,000 crore September 4, 2017 Electromate introduces SMAC LAR55 Actuator July 5, 2018
IoT Connectivity with No Programming Required? Si Labs Releases New Wi-Fi and Bluetooth Modules September 29, 2018